Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
News
Health & Fitness
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/5c/a4/bd/5ca4bd5c-a15e-ff00-953a-38d90521ea5a/mza_6878721867353507492.jpg/600x600bb.jpg
Health Equity in Focus
Third World Network
3 episodes
1 month ago
When Pfizer and other major corporations drafted the rules that became the WTO’s Agreement on Trade-Related Aspects of Intellectual Property (TRIPS), they set global standards that still determine who gets affordable medicines and who doesn’t. Today, those rules are even more evident through the announcement of Trump's tariff deals. Countries are rushing to Washington following the 2 April 2025 announcement of U.S. Reciprocal Tariffs seeking bilateral deals to shield their economies. But what...
Show more...
Social Sciences
Science
RSS
All content for Health Equity in Focus is the property of Third World Network and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
When Pfizer and other major corporations drafted the rules that became the WTO’s Agreement on Trade-Related Aspects of Intellectual Property (TRIPS), they set global standards that still determine who gets affordable medicines and who doesn’t. Today, those rules are even more evident through the announcement of Trump's tariff deals. Countries are rushing to Washington following the 2 April 2025 announcement of U.S. Reciprocal Tariffs seeking bilateral deals to shield their economies. But what...
Show more...
Social Sciences
Science
Episodes (3/3)
Health Equity in Focus
Trump, Trade Deals and Medicines
When Pfizer and other major corporations drafted the rules that became the WTO’s Agreement on Trade-Related Aspects of Intellectual Property (TRIPS), they set global standards that still determine who gets affordable medicines and who doesn’t. Today, those rules are even more evident through the announcement of Trump's tariff deals. Countries are rushing to Washington following the 2 April 2025 announcement of U.S. Reciprocal Tariffs seeking bilateral deals to shield their economies. But what...
Show more...
1 month ago
30 minutes

Health Equity in Focus
Mpox's Lessons on Pandemic Preparedness
For years, Africa grappled with a steady rise in mpox cases and recurring outbreaks, yet the disease remained largely overlooked by the global community. It was only when the virus reached Northern countries that mpox began to garner international attention. This long-standing neglect is evident in the sparse data on the disease, the minimal investment in research and development of medical countermeasures, delayed regulatory approvals, and stark inequities in access to these measures. In t...
Show more...
1 year ago
22 minutes

Health Equity in Focus
Understanding the IHR Amendments
In our inaugural episode, we explore the recent amendments to the International Health Regulations (IHR) and their implications for developing countries, particularly in light of the upcoming session of the Intergovernmental Negotiating Body (INB) negotiating a Pandemic Instrument. The IHR amendments represent a pivotal step towards recognizing the historical inequalities that have long plagued global health systems. Our guest, K.M. Gopakumar, a seasoned researcher and activist from the...
Show more...
1 year ago
19 minutes

Health Equity in Focus
When Pfizer and other major corporations drafted the rules that became the WTO’s Agreement on Trade-Related Aspects of Intellectual Property (TRIPS), they set global standards that still determine who gets affordable medicines and who doesn’t. Today, those rules are even more evident through the announcement of Trump's tariff deals. Countries are rushing to Washington following the 2 April 2025 announcement of U.S. Reciprocal Tariffs seeking bilateral deals to shield their economies. But what...